+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Seizures Epidemiology Forecast 2025-2034

  • PDF Icon

    Report

  • 150 Pages
  • June 2025
  • Region: Global
  • Expert Market Research
  • ID: 6092279
Around 10% of people worldwide will experience at least one seizure in their lifetime. Studies show that approximately 25% to 30% of new-onset seizures are likely to be provoked or secondary to another underlying cause. In older adults, the primary cause of seizures and epilepsy is often related to cerebrovascular disease.

Seizures Epidemiology Forecast Report Coverage

The “Seizures Epidemiology Forecast Report 2025-2034” offers comprehensive information on the prevalence and demographics of seizures. It projects the future incidence and prevalence rates of seizures across various populations. The study covers age, gender, and type as major determinants of the seizures-affected population. The report highlights patterns in the prevalence of seizures over time and projects future trends based on multiple variables.

The report provides a comprehensive overview of the disease, as well as historical and projected data on the epidemiology of seizures in the 8 major markets.

Regions Covered

  • The United States
  • Germany
  • France
  • Italy
  • Spain
  • The United Kingdom
  • Japan
  • India

Seizures: Disease Overview

Seizures are defined as sudden, abnormal bursts of electrical activity in the brain. They can vary in severity and type, with symptoms ranging from brief lapses in awareness to intense shaking or convulsions. Seizures can be caused by conditions like fever, head injuries, infections, low blood sugar, dehydration, or even emotional stress. In some cases, seizures are caused by a brain disorder, such as epilepsy, or an underlying medical condition (a stroke or brain tumor).

Seizures: Treatment Overview

The treatment for seizures depends on the cause, type, and frequency of the seizures. Antiepileptic drugs (AEDs) are the primary treatment for preventing seizures. These medications help control the electrical activity in the brain and reduce the frequency of seizures. In cases where medications are not effective, surgery can be considered as an alternative treatment. Surgical options might include removing the part of the brain that causes the seizures or implanting a device to help regulate brain activity.

Epidemiology

The seizures epidemiology section offers information on the patient pool from history to the present as well as the projected trend for each of the 8 major markets. The publisher provides both current and predicted trends for seizures by examining a wide range of studies. Additionally, the report covers the diagnosed patient pool for seizures and their trends. The data is broken down into specific categories, such as total prevalent cases in males and females, and total diagnosed cases across different age groups and patient pools.
  • According to the World Health Organization (WHO), approximately 10% of people worldwide experience one seizure during their lifetime.
  • As per a 2020 study published in The Lancet, the incidence of epilepsy is highest in both younger and older age groups, with a steady increase in cases after the age of 50. In older adults, the most common cause of seizures and epilepsy is cerebrovascular disease, such as stroke or other issues related to blood flow in the brain.
  • It is estimated that nearly 150,000 people in the United States are diagnosed with epilepsy which causes seizures.
  • Epilepsy is more prevalent in men than women, though the difference is relatively small, as per the Epilepsy Foundation.

Country-wise Seizures Epidemiology

The seizures epidemiology data and findings from the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and India are also provided in the epidemiology section.

The epidemiology of seizures varies between countries, owing to differences in factors such as the prevalence of infections (like meningitis, malaria, or neurocysticercosis), healthcare access, infectious diseases, socioeconomic factors, genetic predispositions, trauma rates, and lifestyle patterns. The Epilepsy Foundation states that around 1 in 100 people experienced a single unproved seizure or had an epilepsy diagnosis in the United States.

Scope of the Report

  • The report covers a detailed analysis of signs and symptoms, causes, risk factors, pathophysiology, diagnosis, treatment options, and classification/types of seizures based on several factors.
  • Seizures Epidemiology Forecast Report covers data for the eight major markets (the US, France, Germany, Italy, Spain, the UK, Japan, and India).
  • The report helps to identify the patient population and the unmet needs of seizures are highlighted along with an assessment of the disease's risk and burden.

Key Questions Answered

  • What are the key findings of seizures epidemiology in the 8 major markets?
  • What will be the total number of patients with seizures across the 8 major markets during the forecast period?
  • What was the country-wise prevalence of seizures in the 8 major markets in the historical period?
  • Which country will have the highest number of seizures patients during the forecast period of 2025-2034?
  • Which key factors would influence the shift in the patient population of seizures during the forecast period of 2025-2034?
  • What are the currently available treatments for seizures?
  • What are the disease risks, signs, symptoms, and unmet needs of seizures?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Introduction
1.2 Objectives of the Study
1.3 Research Methodology and Assumptions
2 Executive Summary
3 Seizures Market Overview - 8 MM
3.1 Seizures Market Historical Value (2018-2024)
3.2 Seizures Market Forecast Value (2025-2034)
4 Seizures Epidemiology Overview - 8 MM
4.1 Seizures Epidemiology Scenario (2018-2024)
4.2 Seizures Epidemiology Forecast (2025-2034)
5 Disease Overview
5.1 Signs and Symptoms
5.2 Causes
5.3 Risk Factors
5.4 Guidelines and Stages
5.5 Pathophysiology
5.6 Screening and Diagnosis
5.7 Types of Seizures
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
7 Epidemiology Scenario and Forecast - 8 MM (218-2034)
7.1 Key Findings
7.2 Assumptions and Rationale
7.3 Diagnosed Prevalent Cases of Seizures
7.4 Type-Specific Cases of Seizures
7.5 Gender-Specific Cases of Seizures
7.6 Age-Specific Cases of Seizures
8 Epidemiology Scenario and Forecast: United States (218-2034)
8.1 Assumptions and Rationale in The United States
8.2 Diagnosed Prevalent Cases of Seizures in The United States
8.3 Type-Specific Cases of Seizures in The United States
8.4 Gender-Specific Cases of Seizures in The United States
8.5 Age-Specific Cases of Seizures in The United States
9 Epidemiology Scenario and Forecast: United Kingdom (218-2034)
9.1 Assumptions and Rationale in the United Kingdom
9.2 Diagnosed Prevalent Cases of Seizures in the United Kingdom
9.3 Type-Specific Cases of Seizures in the United Kingdom
9.4 Gender-Specific Cases of Seizures in the United Kingdom
9.5 Age-Specific Cases of Seizures in the United Kingdom
10 Epidemiology Scenario and Forecast: Germany (218-2034)
10.1 Assumptions and Rationale in Germany
10.2 Diagnosed Prevalent Cases of Seizures in Germany
10.3 Type-Specific Cases of Seizures in Germany
10.4 Gender-Specific Cases of Seizures in Germany
10.5 Age-Specific Cases of Seizures in Germany
11 Epidemiology Scenario and Forecast: France (218-2034)
11.1 Assumptions and Rationale in France
11.2 Diagnosed Prevalent Cases of Seizures in France
11.3 Type-Specific Cases of Seizures in France
11.4 Gender-Specific Cases of Seizures in France
11.5 Age-Specific Cases of Seizures in France
12 Epidemiology Scenario and Forecast: Italy (218-2034)
12.1 Assumptions and Rationale in Italy
12.2 Diagnosed Prevalent Cases of Seizures in Italy
12.3 Type-Specific Cases of Seizures in Italy
12.4 Gender-Specific Cases of Seizures in Italy
12.5 Age-Specific Cases of Seizures in Italy
13 Epidemiology Scenario and Forecast: Spain (218-2034)
13.1 Assumptions and Rationale in Spain
13.2 Diagnosed Prevalent Cases of Seizures in Spain
13.3 Type-Specific Cases of Seizures in Spain
13.4 Gender-Specific Cases of Seizures in Spain
13.5 Age-Specific Cases of Seizures in Spain
14 Epidemiology Scenario and Forecast: Japan (218-2034)
14.1 Assumptions and Rationale in Japan
14.2 Diagnosed Prevalent Cases of Seizures in Japan
14.3 Type-Specific Cases of Seizures in Japan
14.4 Gender-Specific Cases of Seizures in Japan
14.5 Age-Specific Cases of Seizures in Japan
15 Epidemiology Scenario and Forecast: India (218-2034)
15.1 Assumptions and Rationale in India
15.2 Diagnosed Prevalent Cases of Seizures in India
15.3 Type-Specific Cases of Seizures in India
15.4 Gender-Specific Cases of Seizures in India
15.5 Age-Specific Cases of Seizures in India
16 Patient Journey17 Treatment Challenges and Unmet Needs18 Key Opinion Leaders (KOL) Insights